Selected research
Market Analysis & Forecast
Global Companion Animal Healthcare Products Market Analysis and Forecast 2026-2032
Market perspective
The global Companion Animal Healthcare Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Companion Animal Healthcare Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Companion Animal Healthcare Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Companion Animal Healthcare Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Companion Animal Healthcare Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Companion Animal Healthcare Products include CAHIC, Zhongbo Lvya, Zoetis, Pulaike Bio, Jindun Pharma, Virbac, Vetoquinol, Parnell and Ouro Fino Saude, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Companion Animal Healthcare Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Companion Animal Healthcare Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Companion Animal Healthcare Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Companion Animal Healthcare Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Companion Animal Healthcare Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Companion Animal Healthcare Products revenue, projected growth trends, production technology, application and end-user industry.
Companion Animal Healthcare Products Segment by Company
CAHIC
Zhongbo Lvya
Zoetis
Pulaike Bio
Jindun Pharma
Virbac
Vetoquinol
Parnell
Ouro Fino Saude
Norbrook
Merck Animal Health
Meiji
Elanco Animal Health
Dechra Veterinary Products
Ceva
Boehringer Ingelheim
Companion Animal Healthcare Products Segment by Type
Pharmaceuticals
Vaccines
Companion Animal Healthcare Products Segment by Application
Cats
Dogs
Others
Companion Animal Healthcare Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Healthcare Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Healthcare Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Healthcare Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Companion Animal Healthcare Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Companion Animal Healthcare Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Companion Animal Healthcare Products revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceuticals
- Vaccines
Applications
- Cats
- Dogs
- Others
Companies covered
- CAHIC
- Zhongbo Lvya
- Zoetis
- Pulaike Bio
- Jindun Pharma
- Virbac
- Vetoquinol
- Parnell
- Ouro Fino Saude
- Norbrook
- Merck Animal Health
- Meiji
- Elanco Animal Health
- Dechra Veterinary Products
- Ceva
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Companion Animal Healthcare Products Market by Type
- 1.2.1 Global Companion Animal Healthcare Products Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Pharmaceuticals
- 1.2.3 Vaccines
- 1.3 Companion Animal Healthcare Products Market by Application
- 1.3.1 Global Companion Animal Healthcare Products Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Cats
- 1.3.3 Dogs
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Companion Animal Healthcare Products Market Dynamics
- 2.1 Companion Animal Healthcare Products Industry Trends
- 2.2 Companion Animal Healthcare Products Industry Drivers
- 2.3 Companion Animal Healthcare Products Industry Opportunities and Challenges
- 2.4 Companion Animal Healthcare Products Industry Restraints
3 Global Growth Perspective
- 3.1 Global Companion Animal Healthcare Products Market Perspective (2021-2032)
- 3.2 Global Companion Animal Healthcare Products Growth Trends by Region
- 3.2.1 Global Companion Animal Healthcare Products Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Companion Animal Healthcare Products Market Size by Region (2021-2026)
- 3.2.3 Global Companion Animal Healthcare Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Companion Animal Healthcare Products Revenue by Players
- 4.1.1 Global Companion Animal Healthcare Products Revenue by Players (2021-2026)
- 4.1.2 Global Companion Animal Healthcare Products Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Companion Animal Healthcare Products Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Companion Animal Healthcare Products Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Companion Animal Healthcare Products Key Players Headquarters & Area Served
- 4.4 Global Companion Animal Healthcare Products Players, Product Type & Application
- 4.5 Global Companion Animal Healthcare Products Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Companion Animal Healthcare Products Market CR5 and HHI
- 4.6.3 2025 Companion Animal Healthcare Products Tier 1, Tier 2, and Tier 3
5 Companion Animal Healthcare Products Market Size by Type
- 5.1 Global Companion Animal Healthcare Products Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Companion Animal Healthcare Products Revenue by Type (2021-2032)
- 5.3 Global Companion Animal Healthcare Products Revenue Market Share by Type (2021-2032)
6 Companion Animal Healthcare Products Market Size by Application
- 6.1 Global Companion Animal Healthcare Products Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Companion Animal Healthcare Products Revenue by Application (2021-2032)
- 6.3 Global Companion Animal Healthcare Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 CAHIC
- 7.1.1 CAHIC Company Information
- 7.1.2 CAHIC Business Overview
- 7.1.3 CAHIC Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.1.4 CAHIC Companion Animal Healthcare Products Product Portfolio
- 7.1.5 CAHIC Recent Developments
- 7.2 Zhongbo Lvya
- 7.2.1 Zhongbo Lvya Company Information
- 7.2.2 Zhongbo Lvya Business Overview
- 7.2.3 Zhongbo Lvya Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.2.4 Zhongbo Lvya Companion Animal Healthcare Products Product Portfolio
- 7.2.5 Zhongbo Lvya Recent Developments
- 7.3 Zoetis
- 7.3.1 Zoetis Company Information
- 7.3.2 Zoetis Business Overview
- 7.3.3 Zoetis Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.3.4 Zoetis Companion Animal Healthcare Products Product Portfolio
- 7.3.5 Zoetis Recent Developments
- 7.4 Pulaike Bio
- 7.4.1 Pulaike Bio Company Information
- 7.4.2 Pulaike Bio Business Overview
- 7.4.3 Pulaike Bio Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.4.4 Pulaike Bio Companion Animal Healthcare Products Product Portfolio
- 7.4.5 Pulaike Bio Recent Developments
- 7.5 Jindun Pharma
- 7.5.1 Jindun Pharma Company Information
- 7.5.2 Jindun Pharma Business Overview
- 7.5.3 Jindun Pharma Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.5.4 Jindun Pharma Companion Animal Healthcare Products Product Portfolio
- 7.5.5 Jindun Pharma Recent Developments
- 7.6 Virbac
- 7.6.1 Virbac Company Information
- 7.6.2 Virbac Business Overview
- 7.6.3 Virbac Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.6.4 Virbac Companion Animal Healthcare Products Product Portfolio
- 7.6.5 Virbac Recent Developments
- 7.7 Vetoquinol
- 7.7.1 Vetoquinol Company Information
- 7.7.2 Vetoquinol Business Overview
- 7.7.3 Vetoquinol Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.7.4 Vetoquinol Companion Animal Healthcare Products Product Portfolio
- 7.7.5 Vetoquinol Recent Developments
- 7.8 Parnell
- 7.8.1 Parnell Company Information
- 7.8.2 Parnell Business Overview
- 7.8.3 Parnell Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.8.4 Parnell Companion Animal Healthcare Products Product Portfolio
- 7.8.5 Parnell Recent Developments
- 7.9 Ouro Fino Saude
- 7.9.1 Ouro Fino Saude Company Information
- 7.9.2 Ouro Fino Saude Business Overview
- 7.9.3 Ouro Fino Saude Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.9.4 Ouro Fino Saude Companion Animal Healthcare Products Product Portfolio
- 7.9.5 Ouro Fino Saude Recent Developments
- 7.10 Norbrook
- 7.10.1 Norbrook Company Information
- 7.10.2 Norbrook Business Overview
- 7.10.3 Norbrook Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.10.4 Norbrook Companion Animal Healthcare Products Product Portfolio
- 7.10.5 Norbrook Recent Developments
- 7.11 Merck Animal Health
- 7.11.1 Merck Animal Health Company Information
- 7.11.2 Merck Animal Health Business Overview
- 7.11.3 Merck Animal Health Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.11.4 Merck Animal Health Companion Animal Healthcare Products Product Portfolio
- 7.11.5 Merck Animal Health Recent Developments
- 7.12 Meiji
- 7.12.1 Meiji Company Information
- 7.12.2 Meiji Business Overview
- 7.12.3 Meiji Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.12.4 Meiji Companion Animal Healthcare Products Product Portfolio
- 7.12.5 Meiji Recent Developments
- 7.13 Elanco Animal Health
- 7.13.1 Elanco Animal Health Company Information
- 7.13.2 Elanco Animal Health Business Overview
- 7.13.3 Elanco Animal Health Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.13.4 Elanco Animal Health Companion Animal Healthcare Products Product Portfolio
- 7.13.5 Elanco Animal Health Recent Developments
- 7.14 Dechra Veterinary Products
- 7.14.1 Dechra Veterinary Products Company Information
- 7.14.2 Dechra Veterinary Products Business Overview
- 7.14.3 Dechra Veterinary Products Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.14.4 Dechra Veterinary Products Companion Animal Healthcare Products Product Portfolio
- 7.14.5 Dechra Veterinary Products Recent Developments
- 7.15 Ceva
- 7.15.1 Ceva Company Information
- 7.15.2 Ceva Business Overview
- 7.15.3 Ceva Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.15.4 Ceva Companion Animal Healthcare Products Product Portfolio
- 7.15.5 Ceva Recent Developments
- 7.16 Boehringer Ingelheim
- 7.16.1 Boehringer Ingelheim Company Information
- 7.16.2 Boehringer Ingelheim Business Overview
- 7.16.3 Boehringer Ingelheim Companion Animal Healthcare Products Revenue and Gross Margin (2021-2026)
- 7.16.4 Boehringer Ingelheim Companion Animal Healthcare Products Product Portfolio
- 7.16.5 Boehringer Ingelheim Recent Developments
8 North America
- 8.1 North America Companion Animal Healthcare Products Revenue (2021-2032)
- 8.2 North America Companion Animal Healthcare Products Revenue by Type (2021-2032)
- 8.2.1 North America Companion Animal Healthcare Products Revenue by Type (2021-2026)
- 8.2.2 North America Companion Animal Healthcare Products Revenue by Type (2027-2032)
- 8.3 North America Companion Animal Healthcare Products Revenue Share by Type (2021-2032)
- 8.4 North America Companion Animal Healthcare Products Revenue by Application (2021-2032)
- 8.4.1 North America Companion Animal Healthcare Products Revenue by Application (2021-2026)
- 8.4.2 North America Companion Animal Healthcare Products Revenue by Application (2027-2032)
- 8.5 North America Companion Animal Healthcare Products Revenue Share by Application (2021-2032)
- 8.6 North America Companion Animal Healthcare Products Revenue by Country
- 8.6.1 North America Companion Animal Healthcare Products Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Companion Animal Healthcare Products Revenue by Country (2021-2026)
- 8.6.3 North America Companion Animal Healthcare Products Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Companion Animal Healthcare Products Revenue (2021-2032)
- 9.2 Europe Companion Animal Healthcare Products Revenue by Type (2021-2032)
- 9.2.1 Europe Companion Animal Healthcare Products Revenue by Type (2021-2026)
- 9.2.2 Europe Companion Animal Healthcare Products Revenue by Type (2027-2032)
- 9.3 Europe Companion Animal Healthcare Products Revenue Share by Type (2021-2032)
- 9.4 Europe Companion Animal Healthcare Products Revenue by Application (2021-2032)
- 9.4.1 Europe Companion Animal Healthcare Products Revenue by Application (2021-2026)
- 9.4.2 Europe Companion Animal Healthcare Products Revenue by Application (2027-2032)
- 9.5 Europe Companion Animal Healthcare Products Revenue Share by Application (2021-2032)
- 9.6 Europe Companion Animal Healthcare Products Revenue by Country
- 9.6.1 Europe Companion Animal Healthcare Products Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Companion Animal Healthcare Products Revenue by Country (2021-2026)
- 9.6.3 Europe Companion Animal Healthcare Products Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Companion Animal Healthcare Products Revenue (2021-2032)
- 10.2 China Companion Animal Healthcare Products Revenue by Type (2021-2032)
- 10.2.1 China Companion Animal Healthcare Products Revenue by Type (2021-2026)
- 10.2.2 China Companion Animal Healthcare Products Revenue by Type (2027-2032)
- 10.3 China Companion Animal Healthcare Products Revenue Share by Type (2021-2032)
- 10.4 China Companion Animal Healthcare Products Revenue by Application (2021-2032)
- 10.4.1 China Companion Animal Healthcare Products Revenue by Application (2021-2026)
- 10.4.2 China Companion Animal Healthcare Products Revenue by Application (2027-2032)
- 10.5 China Companion Animal Healthcare Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Companion Animal Healthcare Products Revenue (2021-2032)
- 11.2 Asia Companion Animal Healthcare Products Revenue by Type (2021-2032)
- 11.2.1 Asia Companion Animal Healthcare Products Revenue by Type (2021-2026)
- 11.2.2 Asia Companion Animal Healthcare Products Revenue by Type (2027-2032)
- 11.3 Asia Companion Animal Healthcare Products Revenue Share by Type (2021-2032)
- 11.4 Asia Companion Animal Healthcare Products Revenue by Application (2021-2032)
- 11.4.1 Asia Companion Animal Healthcare Products Revenue by Application (2021-2026)
- 11.4.2 Asia Companion Animal Healthcare Products Revenue by Application (2027-2032)
- 11.5 Asia Companion Animal Healthcare Products Revenue Share by Application (2021-2032)
- 11.6 Asia Companion Animal Healthcare Products Revenue by Country
- 11.6.1 Asia Companion Animal Healthcare Products Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Companion Animal Healthcare Products Revenue by Country (2021-2026)
- 11.6.3 Asia Companion Animal Healthcare Products Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Companion Animal Healthcare Products Revenue (2021-2032)
- 12.2 SAMEA Companion Animal Healthcare Products Revenue by Type (2021-2032)
- 12.2.1 SAMEA Companion Animal Healthcare Products Revenue by Type (2021-2026)
- 12.2.2 SAMEA Companion Animal Healthcare Products Revenue by Type (2027-2032)
- 12.3 SAMEA Companion Animal Healthcare Products Revenue Share by Type (2021-2032)
- 12.4 SAMEA Companion Animal Healthcare Products Revenue by Application (2021-2032)
- 12.4.1 SAMEA Companion Animal Healthcare Products Revenue by Application (2021-2026)
- 12.4.2 SAMEA Companion Animal Healthcare Products Revenue by Application (2027-2032)
- 12.5 SAMEA Companion Animal Healthcare Products Revenue Share by Application (2021-2032)
- 12.6 SAMEA Companion Animal Healthcare Products Revenue by Country
- 12.6.1 SAMEA Companion Animal Healthcare Products Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Companion Animal Healthcare Products Revenue by Country (2021-2026)
- 12.6.3 SAMEA Companion Animal Healthcare Products Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst